Patent Approved for Neuronal Cell Transplantation

Pioneering stem cell company Neuralstem, was just issued patent number 12/710,097 entitled “Transplantation of Human Neural Cells for Treatment of Neurodegenerative Conditions.” The patent covers technology that allows for neuronal cells grown in the lab to be transplanted into the spinal cord of a patient. Neuralstem is currently running an ongoing Phase I clinical trial of its stem cell technology, and just treated their seventeenth patient.

Click here to read more.

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail